Figure 4.

Effect of cMyBP-C ablation on Ca 2+ handling in hiPSC-ECT. (A and B) Absolute (A) and normalized (B) averaged Ca2+ transient (Ca2+TR) traces in day 40–54 cMyBP-C+/+ (broken traces), cMyBP-C+/− (grey traces), and cMyBP-C−/− (black traces) hiPSC-ECTs loaded with Fura2-AM. (C) Normalized average traces focusing on the time from Ca2+ peak to 50% Ca2+-transient decay (Ca2+DT50). (D–G) Box and whisker plots of cytoplasmic Ca2+-transient amplitude as estimated by the ∆F340/F380 ratio (Ca2+TR; D); time to Ca2+-transient peak (Ca2+T100; E); time from Ca2+-transient peak to 50% decay (Ca2+DT50; F) and time from 50 to 75% Ca2+-transient decay (Ca2+DT50-75; G) in hiPSC-ECT. All experiments were performed at 37°C with pacing at 1.5 Hz. n ≥ 11 biological replicates; *P < 0.05; **P < 0.01; ***P < 0.001 as calculated by one-way ANOVA with Tukey’s multiple comparisons test; see Table S7 for specific P values.

or Create an Account

Close Modal
Close Modal